Economy
Families Beat the Back-to-School Cost Crunch With £5 Second-Hand Uniforms
A shop offering second-hand school uniforms for £5 highlights growing pressure on household budgets as education costs rise across the UK.
Author
The Fiscalist
Markets
Fed Rate Outlook Drags Comex Gold and Silver to Session Lows as Dollar Firms
Gold and silver futures on Comex settled lower as traders awaited the Federal Reserve’s rate decision, boosting the dollar.
Investing
Analyst Upgrades SpaceX to Buy as Rocket Lab Climbs on Successful Electron Launch
SpaceX receives a Wall Street upgrade tied to AI infrastructure spending, while Rocket Lab shares rally after a successful Electron rocket mission.
Policy
Israel Faces a $133 Billion Reckoning Over How to Pay for a Transformed Military
Israel’s government is locked in a fierce debate over a $133 billion defense plan that could reshape public spending for years to come.
Investing
Palantir’s Karp Says Business Has Doubled, Sending a Clear Signal to Shareholders
Palantir CEO Alex Karp declared the company’s business has doubled, sparking fresh investor interest in the high-flying AI data analytics firm.
Policy
Florida Fire Commissioner Backs Carbonara in Southwest Florida Congressional Race
Greater Naples Fire Commissioner Patrick Dearborn endorses Michael Carbonara for Congress, citing public safety and fiscal responsibility priorities.
Banking
Banks, Insurers, and Asset Managers Draw Analyst Scrutiny as Sector Commentary Intensifies
Analysts weigh in on banks, insurers, and asset managers as fresh market commentary shapes expectations across the financial services sector.
Corporate
Lifetime Brands Reports Mixed Q2 2026 Results as Tariff Pressures Weigh on Margins
Lifetime Brands posts Q2 2026 results amid tariff headwinds, with management outlining cost mitigation strategies and cautious full-year guidance.
Markets
Data Center Earnings Season Heats Up as CoreWeave, Nebius, and Chip Giants Prepare to Report
CoreWeave, Nebius, Lumentum, and Applied Materials headline a busy earnings week for AI infrastructure and semiconductor stocks.
Corporate
Immunovant Advances Pipeline and Trims Losses as Fiscal First Quarter Results Signal Clinical Momentum
Immunovant’s Q1 2027 earnings call highlighted pipeline progress, reduced operating losses, and advancing clinical data for its FcRn inhibitor platform.